A Practical, Risk-Stratified Guide to Colorectal Cancer Screening In India

By Dr. Avinash Deo, Medical Oncologist

September 13, 2025

The Conversation in Your Clinic Has Changed

For decades, the magic number for colorectal cancer (CRC) screening was 50. But that has changed. A 45-year-old now sitting in your office is a candidate for screening. A 38-year-old who mentions her father had colon cancer at 48 requires a completely different, more urgent plan.

With the rising incidence of CRC in younger adults, a one-size-fits-all approach is no longer adequate. Our role as primary care physicians is to act as skilled risk stratifiers, ensuring every patient gets the right screening, at the right time. This simple framework, based on current national guidelines, can help streamline that process in a busy clinic.

Category 1: The Average-Risk Individual

This group represents the majority of our patients and the new standard of care.

Who They Are:

• Age 45 or older.
• No personal history of colorectal cancer or advanced polyps.
• No significant family history (see next section).
• No personal history of inflammatory bowel disease (IBD).

Your Management Plan:

• Start Screening at Age 45. This significant change from the previous recommendation of age 50 is a guideline supported by major U.S. bodies, including the U.S. Preventive Services Task Force (USPSTF) and the American Cancer Society (ACS). The decision was driven by compelling evidence of a rising incidence of colorectal cancer in adults under 50, with epidemiological data and modeling studies showing that beginning screening at 45 provides a more optimal balance of benefit and risk for the average-risk population.
• Offer Tiered Options:

• Tier 1 (Preferred): Colonoscopy. The gold standard. If normal, repeat every 10 years.
• Tier 2 (Alternative): Stool-Based Tests. Excellent options for patients who decline or cannot undergo colonoscopy. A positive result from any of these tests must be followed by a colonoscopy.

• FIT (Fecal Immunochemical Test): Annually.
• Stool DNA Test (e.g., Cologuard): Every 3 years.

Clinical Pearl: The best test is the one that gets done. While colonoscopy is preferred because it can both detect and prevent cancer by removing polyps, offering alternatives is a crucial strategy to increase overall screening adherence.

Category 2: The Individual with Increased / Moderate Risk

This is where a thoughtful family history becomes critical. Asking “Has anyone in your immediate family had colon cancer or polyps?” can change the entire management plan.

Who They Are:

• A personal history of CRC or certain types of polyps (e.g., adenomas).
• A family history of CRC or advanced polyps in a first-degree relative (parent, sibling, child) before age 60.
• A family history of CRC in two or more first-degree relatives at any age.

Your Management Plan:

• Start Screening Earlier and Repeat More Frequently.
• When to Start: Age 40, OR 10 years before the youngest case in the immediate family, whichever comes first.
• Example: A patient’s mother was diagnosed at age 48. The patient should start screening at age 38.

• What Test: Colonoscopy is the only recommended test for this group.
• How Often: Repeat every 3 to 5 years, depending on the findings and the specific family history.

Category 3: The High-Risk Individual (Hereditary Syndromes)

This is the smallest group, but identifying them is paramount. These individuals have genetic syndromes that confer a very high lifetime risk of CRC and require specialist management. Your role is to recognize the red flags and refer appropriately.

Who They Are:

• Known diagnosis or a very strong family history suggestive of:

• Lynch Syndrome (HNPCC): Associated with CRC, endometrial, ovarian, stomach, and other cancers.
• Familial Adenomatous Polyposis (FAP): Characterized by the development of hundreds to thousands of polyps in the colon.

Your Management Plan: Urgent Referral and Aggressive Surveillance

• Lynch Syndrome:
• Colonoscopy: Begin between ages 20-25, and repeat every 1-2 years.
• Familial Adenomatous Polyposis (FAP):

• Sigmoidoscopy/Colonoscopy: Begin between ages 10-15, and repeat annually.
• Discuss Prophylactic Surgery: Prophylactic colectomy (removal of the colon) is the standard of care, as cancer is otherwise inevitable.

Clinical Pearl: A family history with multiple members across generations with CRC, or with related cancers like uterine and ovarian, should be a major red flag for Lynch Syndrome and prompt a referral to genetics and gastroenterology.

At-a-Glance Summary

Risk Category	Key Definition	Recommended Screening
Average Risk	Age ≥45, no major risk factors	Start at 45. Colonoscopy every 10 years OR stool test annually/triennially.
Increased Risk	Personal/strong family history (CRC/polyps <60)	Start at 40 (or 10 yrs before youngest case). Colonoscopy every 3-5 years.
High Risk	Lynch Syndrome, FAP	Start in teens/20s. Colonoscopy every 1-2 years. Refer to specialist.

The Indian Context: A Practical Approach

While the above guidelines represent the gold standard in many Western countries, we must adapt them to the realities of practicing in India.

Current Status of Screening in India:

As of 2025, India does not have a national, population-based screening program for colorectal cancer. The consensus from bodies like the Indian Society of Gastroenterology (ISG) leans towards opportunistic screening rather than a mass, government-led initiative. This places the responsibility squarely on us, as clinicians, to identify appropriate candidates during their routine visits.

Why Can’t We Directly Follow Western Guidelines?

1. Resource and Infrastructure Constraints: The number of trained gastroenterologists and endoscopy suites per capita is extremely low, especially outside of major metropolitan centres. A population-wide, colonoscopy-based screening program starting at age 45 is not currently feasible.
2. Cost and Accessibility: A colonoscopy is a significant out-of-pocket expense for a majority of the population. The accessibility and affordability of simpler tests like FIT are far greater.
3. Epidemiological Differences: While the incidence of CRC is rising in India, it remains lower than in the West. However, evidence suggests that a significant proportion of Indian patients are diagnosed at a younger age (often below 50) and at more advanced stages. This creates a paradox: while mass screening is not yet cost-effective, a significant number of younger, symptomatic patients are falling through the cracks.

A Pragmatic Screening Consensus for India:

• For Increased and High-Risk Individuals: The guidelines are universal. These patients must be identified and managed aggressively with colonoscopy as described in Category 2 and 3. Your role in taking a detailed family history is paramount.
• For Average-Risk Individuals:

• The consensus is to begin the screening conversation at age 45-50.
• Given the barriers to colonoscopy, an annual FIT test is an excellent and practical first-line screening tool. It is inexpensive and widely available.
• Emphasize that a positive FIT is not a diagnosis but a trigger for a mandatory colonoscopy. This follow-through is crucial.
• Colonoscopy can be offered as a primary option for those who can afford it and have access, with the interval extended to 10 years if negative.

The Bottom Line

Our approach to colorectal cancer screening has become more precise. By categorizing every adult patient into one of these three tiers, we can move beyond a simple age-based recommendation. In the Indian context, this means aggressively pursuing colonoscopy for high-risk individuals while championing pragmatic, opportunistic screening with tools like FIT for the average-risk population. A few targeted questions about personal and family history can ensure our patients receive the personalized screening strategy they need—a strategy that can be the difference between early detection and advanced disease.